跳至主要内容
临床试验/NL-OMON48731
NL-OMON48731招募中不适用

MAGnesium In Chronic HemoDialysis; A clinical trial assessing the feasibility of increasing plasma magnesium concentrations by means of increasing dialysate magnesium concentrations in chronic hemodialysis patients. - MAGIC-HD

Vrije Universiteit Medisch Centrum0 个研究点目标入组 53 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
53

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Age 18 or above
  • - Hemodialysis with regular three times weekly dialysis schedule
  • - Hemodialysis since at least 3 months
  • - Standard dialysate Mg2+ concentration 0.50 mmol/L
  • - Providing informed consent
  • - Pre-dialysis plasma magnesium concentration 1.00 mmol/L or below

排除标准

  • - Intravenous magnesium supplementation (including total parenteral nutrition)
  • in the last 2 weeks
  • - Expected cessation of hemodialysis treatment within three months after
  • inclusion or expected permanent or temporary dialysis center switch to a center
  • not participating in the trial within three months after inclusion.
  • - Prolongation of QTc interval: male >450ms or female >460ms on baseline ECG
  • - Bradycardia: heart rate below 60 beats per minute on baseline ECG
  • - Chronic arrythmia or cardiac conduction disorder other than atrial
  • fibrillation or ventricular extrasystole that poses the patient at risk at the
  • discretion of the treating physician.
  • - Change of protonpumpinhibitor prescription in the last 2 weeks

研究者

相似试验

MAGnesium In Chronic HemoDialysis; A clinical trial... | 临床试验